RCS - Envista - DEXIS Reflects on a Year of Innovation

Envista HoldingsAnnouncement

03/02/2025 15:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250203:nRSC6941Va&default-theme=true

RNS Number : 6941V  Envista  03 February 2025

DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025

QUAKERTOWN, PA / ACCESS Newswire / February 3, 2025 / DEXIS, an international
leader in dental imaging technologies, celebrates the 2024 launch of its DEXIS
digital ecosystem along with other AI-powered imaging solutions. The company
also announces that 2025 will bring further innovations, with presentations at
two major dental technology conferences.

Related Image:
(https://cdn.nwe.io/files/x/a3/8d/946eec1d85369aa27a252b349fed.png)

"For DEXIS, 2024 was a year of tremendous innovation, as we continue to
provide dental professionals with the most powerful, efficient and time-saving
diagnostic tools and technologies," DEXIS President Robert Befidi said. "We
are proud of our progress and will bring that momentum with us in 2025 as we
unveil exciting, industry-changing initiatives."

The company enhanced its portfolio of award-winning imaging solutions in 2024,
beginning with the February 2024 launch of the DEXIS digital ecosystem
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cubmV3c3dpcmUuY29tL25ld3MvZGV4aXMtZHJpdmVzLWRlbnRhbC1pbWFnaW5nLWlubm92YXRpb24td2l0aC1pbnRyb2R1Y3Rpb24tb2YtYWktcG93ZXJlZC0yMjI0MDMzNA&sig=zvxuXQ-3AiYLntahMMw-T-93x6fQZDUc05kbaR4RmtnjRhSrKL6pS7KEUQ8J1DtwZxO9oSzb5fi6bVDNB_Z-Dw&hit%2Csum=WyI0cjJ4YmoiLCI0cjJ4YmsiLCI0cjJ4YmwiXQ)
, a suite of tools and software designed to connect and streamline the implant
workflow. The platform combines cutting-edge CBCT, intraoral scanning,
diagnostics, and treatment planning to aid clinicians through their entire
digital workflow from diagnosis to delivery. The open imaging system ensures
that clinicians have the freedom to customize workflows and that patients,
labs, and staff have the appropriate visibility, creating a seamless
experience.

May 2024 brought the release of the DEXIS Ti2 Intraoral Sensor
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cubmV3c3dpcmUuY29tL25ld3MvZGV4aXMtaW5ub3ZhdGlvbi1jb250aW51ZXMtd2l0aC1uZXctZGV4aXMtdGkyLXNlbnNvci1hcy1zdWNjZXNzb3ItdG8tMjIzMzE2ODg&sig=rzjxkufiZmByWJVT46Ir0699YcLtWW2-Vgrtu2ICKfRsD-bqJCYOOHaVjgVUeLvgnYKr5z2zdVGRy9diJcGKDw&hit%2Csum=WyI0cjJ4Ym0iLCI0cjJ4Ym4iLCI0cjJ4YmwiXQ)
, built on the success of its predecessor, the best-selling DEXIS Titanium
Sensor. The Ti2 sensor provides high-resolution images while also adding 2D AI
Dental Findings, an integrated offering that automatically identifies and
highlights 6 common dental findings. The sensor's housing also incorporates
subtle design changes that make it more resistant to drops and wear.

In August, the company announced the launch of DEXIS™ Connect Pro
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cubmV3c3dpcmUuY29tL25ld3MvZGV4aXMtbGF1bmNoZXMtZGV4aXMtY29ubmVjdC1wcm8tYS1uZXctcHJvYWN0aXZlLXNlcnZpY2UtcGxhdGZvcm0tZm9yLTIyNDA1NTc5&sig=bVF8pixzlW43kjfzWnEQD0MsfNuTW-AgguTIIp91FpRKvZuIGw14LBoHw6fLtBo9L61vfP3xUq7IWLGQbtLqKQ&hit%2Csum=WyI0cjJ4Ym8iLCI0cjJ4YnAiLCI0cjJ4YmwiXQ)
, which provides proactive monitoring of DEXIS CBCT and intraoral sensor
devices through IoT technology. It connects DEXIS customers with more than 100
DEXIS technical support agents, automatically arranging support, preventative
maintenance, or equipment replacements if performance issues are detected. By
keeping digital equipment operating without interruption, the Connect Pro
solution enhances office productivity and consistent patient care for dental
professionals who rely on DEXIS technology.

DEXIS continued to actively improve its solutions with the September 2024
release of the ORTHOPANTOMOGRAPH™ OP 3D™ EX X-ray platform
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cubmV3c3dpcmUuY29tL25ld3MvZGV4aXMtZGlnaXRhbC1lY29zeXN0ZW0tZXhwYW5kcy13aXRoLTMtbmV3LWlubm92YXRpb25zLXRvLXN0cmVhbWxpbmUtMjI0MjkyNDI&sig=QF8LYWI1smtow7Ia7cxPtU7mvaKHSS-cK6-1aueMidwhKTkEja2c-BKacOby9FA8-ML0cH7x84gxHyA_y09o1w&hit%2Csum=WyI0cjJ4YnEiLCI0cjJ4YnIiLCI0cjJ4YmwiXQ)
. Designed specifically for general practitioners looking to expand their
diagnostic capabilities with 3D imaging, the OP 3D EX has a wide range of
field of view sizes to support multiple clinical indications. Updates to
the DTX Studio™ Clinic software provided advanced tools and new
functionality that allows practitioners to plan an implant treatment and
generate a surgical guide chairside, in less than three minutes.

DEXIS envisions 2025 as another year of ground-breaking advancements in
technology and customer service. Projects currently in production or
development include:

·      The first intraoral scanner developed entirely by DEXIS

·      AI enhancements across the ecosystem to increase efficiency and
productivity

·      An exciting innovation within the 3D imaging portfolio

·      Updates to enhance the implant workflow in DTX Studio Clinic

DEXIS expects to begin rolling out these initiatives at two major 2025
industry meetings: the Chicago Dental Society Midwinter Meeting in February
and the International Dental Show in Cologne, Germany, in March.

The Chicago Dental Society meeting, February 20-25 at McCormick Place West, is
the organization's 160(th) annual midwinter conference and offers more than
200 courses on dental medicine. It draws both U.S. and international dental
professionals as well as hundreds of exhibitors.

The International Dental Show, March 25-29, is the world's leading trade fair
for the dental sector. The biennial event is known as a trend-setting event,
where major manufacturers unveil advances in technology for the top
decision-makers in dentistry.

As one of the world's leading developers of dental imaging technologies, DEXIS
sees both events as essential venues for showcasing its products and
connecting with DEXIS owners." There are more than 150,000 DEXIS dental
imaging devices in use worldwide which is a testament to our mission to
transform practices and patient smiles globally," Befidi said. "Every year, we
build on our long tradition of innovation and successes, learn from our
lessons, and aim to provide innovative solutions and exceptional service to
our customers."

Visit the company's website at www.dexis.com to stay informed about the
latest industry news, product information, and upcoming events.

About DEXIS

DEXIS
(https://stats.newswire.com/x/html?final=aHR0cDovL3d3dy5kZXhpcy5jb20vP3V0bV9zb3VyY2U9TmV3c3dpcmUmdXRtX21lZGl1bT1QUiZ1dG1fY2FtcGFpZ249REVYSVNfaW50cmFvcmFsX3NjYW5uZXJfaW50ZWdyYXRpb25fRWFzeVJ4&sig=T0MWRNFk3gXHXGK2NxFYIled_GFwa6gKWYZsXGvunRtt7o5j7el3GNeacYKT9k6jSfXZzo_h3xx7X1omrk48nA&hit%2Csum=WyI0MWRkM3ciLCI0MWRkM3giLCI0MWRkM3kiXQ)
 has been a global leading brand in digital radiography for 70+ years. Today,
DEXIS has brought together the most trusted brands in 3D imaging, intraoral
scanning solutions, and diagnostic software to provide you with a complete
digital diagnostic solution under a brand name. Our innovative award-winning
technology enhances the way you diagnose, accelerates your workflow, and
delivers simpler treatment paths with better patient outcomes. For more
information, please visit https://www.dexis.com.
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9kZXhpcy5jb20vZW4tdXM_dXRtX3NvdXJjZT1OZXdzd2lyZSZ1dG1fbWVkaXVtPVBSJnV0bV9jYW1wYWlnbj1EZXhpc19BSV9JbXBsYW50&sig=8ex8Lm3xhOd02I_YCiUQdqjgwul4HqtBGvQkcyNopr0NAZl0OPtV8GzVFk1P5ETEfGLxAbc4bvZf2D46-FZIiw&hit%2Csum=WyI0NzNvZDIiLCI0NzNvZDkiLCI0NzNvZDQiXQ)

About Envista Holdings Corporation

Envista
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9lbnZpc3RhY28uY29tL2Vu&sig=kehsVyQjZPsUpgaCFa26919tdMe0JfLrZo4UTBi1sGwXi35DbNYAaVa6H_FNr_oCNcewmsJLEswvemQvvfdEpA&hit%2Csum=WyI0cjJ4YnMiLCI0cjJ4YnQiLCI0cjJ4YmwiXQ)
 is a global family of more than 30 trusted dental brands, including Nobel
Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with
professionals to improve lives. Envista helps its customers deliver the best
possible patient care through industry-leading dental consumables, solutions,
technology, and services. Its comprehensive portfolio, including dental
implants and treatment options, orthodontics, and digital imaging
technologies, covers a wide array of dentists' clinical needs for diagnosing,
treating, and preventing dental conditions as well as improving the aesthetics
of the human smile. With a foundation comprised of the proven Envista Business
System (EBS) methodology, an experienced leadership team, and a strong culture
grounded in continuous improvement, commitment to innovation, and deep
customer focus, Envista is well equipped to meet the end-to-end needs of
dental professionals worldwide. Envista is one of the largest global dental
products companies, with significant market positions in some of the most
attractive segments of the dental products industry. For more information,
please visit www.envistaco.com.
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9jMjEyLm5ldC9jL2xpbmsvP3Q9MCZsPWVuJm89NDI0MTIwOS0xJmg9NDAxMDQ2NTAyOCZ1PWh0dHAlM0ElMkYlMkZ3d3cuZW52aXN0YWNvLmNvbSUyRiZhPXd3dy5lbnZpc3RhY28uY29tJnV0bV9zb3VyY2U9TmV3c3dpcmUmdXRtX21lZGl1bT1QUiZ1dG1fY2FtcGFpZ249REVYSVNfSW5ub3ZhdGlvbnM&sig=nDZNmniSkr31agoSo4aFkd-UhABgI5jgoLcpBRPkoB2ltEsJ-NlAoheBT0mJqGsZnigHLLhXCWzm9wUIUWJbeg&hit%2Csum=WyI0amE3aXgiLCI0amE3aXkiLCI0amE3aXYiXQ)

Contact Information

Maria Penaloza

Media & Content Strategy Manager

maria.penaloza@issuerdirect.com

Julie Hansoulle

Sr. Marketing Manager DEXIS EU

julie.hansoulle@envistaco.com

SOURCE: Envista

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRALXLFBELLLBBK